Hbk Sorce Advisory LLC Heron Therapeutics, Inc. Transaction History
Hbk Sorce Advisory LLC
- $3.02 Billion
- Q3 2025
A detailed history of Hbk Sorce Advisory LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Hbk Sorce Advisory LLC holds 10,000 shares of HRTX stock, worth $11,800. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,307
2.98%
Holding current value
$11,800
Previous $13,000
7.69%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HRTX
# of Institutions
184Shares Held
128MCall Options Held
1.56MPut Options Held
27.1K-
Rubric Capital Management LP New York, NY26.7MShares$31.5 Million1.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.47MShares$10 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$9.82 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA7.85MShares$9.27 Million0.03% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$8.24 Million24.86% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $140M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...